Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dulening vs Metformin for Type 2 Diabetes Mellitus (Phase 4, Multicenter, China)
ChiCTR2000041280Phase 4Recruiting
- Sponsor
- Beijing Hospital
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of DuLeNing in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Beijing Hospital. Primary endpoint: HbA1c change from baseline. Started May 2015; status: recruiting.
02
Drugs
DuLeNing
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR2000041280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000041280.